Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

05-12-2022 | Bronchiectasis | Original Article

Necroptosis-related subtypes are associated with bronchiectasis in pulmonary non-tuberculous mycobacteria-infected patients: a perspective based on transcriptomic analysis

Authors: Hao Qian, Ai Ge, Ji-Jin Jiang, Jin-Fu Xu

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2023

Abstract

The aim of this study was to explore the potential mechanisms responsible for the different manifestations of bronchiectasis in patients with pulmonary non-tuberculous mycobacteria (pNTM) infection. We found that the necroptosis level increased significantly after NTM infection. Further, the 31 pNTM-infected patients were classified into two subtypes based on necroptosis-related genes (NRGs) by unsupervised cluster analysis. After that, we compared the differences in clinical parameters, immune cell infiltration, and gene expression between the two subtypes. We observed that the high-necroptosis subtype possessed higher CT scores for bronchiectasis extent (P = 0.008) and severity (P = 0.023). And, more neutrophil infiltration in the high-necroptosis subtype was demonstrated both by the CIBERSORT algorithm and by blood neutrophil count (P = 0.001). Next, 688 differentially expressed genes (DEGs) between two subtypes were identified. To explore the portion in DEGs that might contribute to bronchiectasis, we intersected the DEGs with two gene modules. These two gene modules were identified as the most associated with CT scores for bronchiectasis extent and severity by weighted gene co-expression network analysis (WGCNA). Ninety-three intersection genes were obtained. Finally, 7 hub genes including ACSL1, ANXA3, DYSF, HK3, SLC11A1, STX11, and TLR4 were further screened out by machine learning algorithms and protein–protein interaction network analysis. These results suggested that the differential levels of necroptosis in pNTM patients might lead to differential extent and severity of bronchiectasis on radiographic imaging. This process might be associated with neutrophil infiltration and the involvement of seven hub genes.

Available only for authorised users

Park IK, Olivier KN (2015) Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis. Semin Respir Crit Care Med 36(2):217–224. https://doi.org/10.1055/s-0035-1546751CrossRef

Tan S, Kasperbauer S (2021) Nontuberculous mycobacteria. Semin Respir Crit Care Med 42(4):567–586. https://doi.org/10.1055/s-0041-1730997CrossRef

Cowman SA, Loebinger MR (2018) Diagnosis of nontuberculous mycobacteria lung disease. Semin Respir Crit Care Med 39(3):343–350. https://doi.org/10.1055/s-0038-1651493CrossRef

Youssefnia A, Pierre A, Hoder JM, MacDonald M, Shaffer MJB, Friedman J, Mehler PS, Bontempo A, da Silva FCN, Chan ED (2022) Ancillary treatment of patients with lung disease due to non-tuberculous mycobacteria: a narrative review. J Thorac Dis 14(9):3575–3597. https://doi.org/10.21037/jtd-22-410CrossRef

Lange C, Böttger EC, Cambau E, Griffith DE, Guglielmetti L, van Ingen J, Knight SL, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, Wagner D, Winthrop K, Daley CL (2022) Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. Lancet Infect Dis 22(7):e178–e190. https://doi.org/10.1016/S1473-3099(21)00586-7CrossRef

Pathak K, Hart S, Lande L (2022) Nontuberculous mycobacteria lung disease (NTM-LD): current recommendations on diagnosis, treatment, and patient management. Int J Gen Med 15:7619–7629. https://doi.org/10.2147/IJGM.S272690CrossRef

Anjos LRBD, Parreira PL, Torres PPTS, Kipnis A, Junqueira-Kipnis AP, Rabahi MF (2020) Non-tuberculous mycobacterial lung disease: a brief review focusing on radiological findings. Rev Soc Bras Med Trop 53:e20200241. https://doi.org/10.1590/0037-8682-0241-2020CrossRef

Linkermann A, Green DR (2014) Necroptosis. N Engl J Med 370(5):455–465. https://doi.org/10.1056/NEJMra1310050CrossRef

Choi ME, Price DR, Ryter SW, and Choi AMK (2019) Necroptosis: a crucial pathogenic mediator of human disease. JCI Insight, 4(15).https://doi.org/10.1172/jci.insight.128834

10.

Lee J-M, Yoshida M, Kim M-S, Lee J-H, Baek A-R, Jang AS, Kim DJ, Minagawa S, Chin SS, Park C-S, Kuwano K, Park SW, Araya J (2018) Involvement of alveolar epithelial cell necroptosis in idiopathic pulmonary fibrosis pathogenesis. Am J Respir Cell Mol Biol 59(2):215–224. https://doi.org/10.1165/rcmb.2017-0034OCCrossRef

11.

Lu Z, Van Eeckhoutte HP, Liu G, Nair PM, Jones B, Gillis CM, Nalkurthi BC, Verhamme F, Buyle-Huybrecht T, Vandenabeele P, VandenBerghe T, Brusselle GG, Horvat JC, Murphy JM, Wark PA, Bracke KR, Fricker M, Hansbro PM (2021) Necroptosis signaling promotes inflammation, airway remodeling, and emphysema in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 204(6):667–681. https://doi.org/10.1164/rccm.202009-3442OCCrossRef

12.

Cowman SA, Jacob J, Hansell DM, Kelleher P, Wilson R, Cookson WOC, Moffatt MF, Loebinger MR (2018) Whole-blood gene expression in pulmonary nontuberculous mycobacterial infection. Am J Respir Cell Mol Biol 58(4):510–518. https://doi.org/10.1165/rcmb.2017-0230OCCrossRef

13.

Zoumot Z, Boutou AK, Gill SS, van Zeller M, Hansell DM, Wells AU, Wilson R, Loebinger MR (2014) Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis. Respirology 19(5):714–722. https://doi.org/10.1111/resp.12287CrossRef

14.

Nakajima M, Matsuyama M, Kawaguchi M, Matsumura S, Kiwamoto T, Matsuno Y, Morishima Y, Yoshida K, Sherpa MT, Yazaki K, Tanaka R, Okiyama N, Muratani M, Ishii Y, Hizawa N (2021) Depletion of PD-1 or PD-L1 did not affect the mortality of mice infected with Mycobacterium avium. Sci Rep 11(1):18008. https://doi.org/10.1038/s41598-021-97391-4CrossRef

15.

Zhang C, Asif H, Holt GE, Griswold AJ, Campos M, Bejarano P, Fregien NL, Mirsaeidi M (2019) Bronchial epithelial cells cross-talk through type I interferon signaling. Front Immunol 10:2888. https://doi.org/10.3389/fimmu.2019.02888CrossRef

16.

Wang Y, Huang Y, Li C, Wang X, Yang M, Xu D, Liu B, Yuan X (2022) Establishment of a necroptosis related genes signature to predict prognosis and therapeutic response in colon cancer. Front Cell Dev Biol 10:921320. https://doi.org/10.3389/fcell.2022.921320CrossRef

17.

Wilkerson MD, Hayes DN (2010) ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26(12):1572–1573. https://doi.org/10.1093/bioinformatics/btq170CrossRef

18.

Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12(5):453–457. https://doi.org/10.1038/nmeth.3337CrossRef

19.

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47. https://doi.org/10.1093/nar/gkv007CrossRef

20.

Ito K, Murphy D (2013) Application of ggplot2 to Pharmacometric Graphics. CPT Pharmacometrics Syst Pharmacol 2:e79. https://doi.org/10.1038/psp.2013.56CrossRef

21.

Yu G, Wang L-G, Han Y, He Q-Y (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284–287. https://doi.org/10.1089/omi.2011.0118CrossRef

22.

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545–15550CrossRef

23.

Strobl C, Boulesteix A-L, Zeileis A, Hothorn T (2007) Bias in random forest variable importance measures: illustrations, sources and a solution. BMC Bioinformatics 8:25CrossRef

24.

Scharl T, Grü B, Leisch F (2010) Mixtures of regression models for time course gene expression data: evaluation of initialization and random effects. Bioinformatics 26(3):370–377. https://doi.org/10.1093/bioinformatics/btp686CrossRef

25.

Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8(Suppl 4):S11. https://doi.org/10.1186/1752-0509-8-S4-S11CrossRef

26.

Wang C, Tang Y, Ma H, Wei S, Hu X, Zhao L, Wang G (2022) Identification of hypoxia-related subtypes, establishment of prognostic models, and characteristics of tumor microenvironment infiltration in colon cancer. Front Genet 13:919389. https://doi.org/10.3389/fgene.2022.919389CrossRef

27.

Lai M, Liu Q, Chen W, Qi X, Yang J, Jiang L, Yuan M, Liu Z, He Q, Cao J, Yang B (2022) Identification and validation of two heterogeneous molecular subtypes and a prognosis predictive model for hepatocellular carcinoma based on pyroptosis. Oxid Med Cell Longev 2022:8346816. https://doi.org/10.1155/2022/8346816CrossRef

28.

Giam YH, Shoemark A, and Chalmers JD (2021) Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism. Eur Respir J, 58(2).https://doi.org/10.1183/13993003.03157-2020

29.

Bonaiti G, Pesci A, Marruchella A, Lapadula G, Gori A, Aliberti S (2015) Nontuberculous mycobacteria in noncystic fibrosis bronchiectasis. Biomed Res Int 2015:197950. https://doi.org/10.1155/2015/197950CrossRef

30.

Kaczmarek A, Vandenabeele P, Krysko DV (2013) Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38(2):209–223. https://doi.org/10.1016/j.immuni.2013.02.003CrossRef

31.

Flume PA, Chalmers JD, Olivier KN (2018) Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet 392(10150):880–890. https://doi.org/10.1016/S0140-6736(18)31767-7CrossRef

32.

He A, Chen J, Guan J, Huang Y, Xie H, Chen H, Wen Y, Chen Q, Xie S, Li H, Ou C, Zhang Q, Tao A, Yan J (2022) Selective eosinophil necroptosis contributes to airway inflammation and remodeling in asthma. Allergy. https://doi.org/10.1111/all.15448CrossRef

33.

Malcolm KC, Caceres SM, Pohl K, Poch KR, Bernut A, Kremer L, Bratton DL, Herrmann J-L, Nick JA (2018) Neutrophil killing of Mycobacterium abscessus by intra- and extracellular mechanisms. PLoS ONE 13(4):e0196120. https://doi.org/10.1371/journal.pone.0196120CrossRef

34.

Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303(5663):1532–1535CrossRef

35.

Papayannopoulos V (2018) Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 18(2):134–147. https://doi.org/10.1038/nri.2017.105CrossRef

36.

Nakamura K, Nakayama H, Sasaki S, Takahashi K, Iwabuchi K (2022) Mycobacterium avium-intracellulare complex promote release of pro-inflammatory enzymes matrix metalloproteinases by inducing neutrophil extracellular trap formation. Sci Rep 12(1):5181. https://doi.org/10.1038/s41598-022-09017-yCrossRef

37.

Desai J, Kumar SV, Mulay SR, Konrad L, Romoli S, Schauer C, Herrmann M, Bilyy R, Müller S, Popper B, Nakazawa D, Weidenbusch M, Thomasova D, Krautwald S, Linkermann A, Anders H-J (2016) PMA and crystal-induced neutrophil extracellular trap formation involves RIPK1-RIPK3-MLKL signaling. Eur J Immunol 46(1):223–229. https://doi.org/10.1002/eji.201545605CrossRef

38.

Zhang K, Huang Q, Deng S, Yang Y, Li J, Wang S (2021) Mechanisms of TLR4-mediated autophagy and nitroxidative stress. Front Cell Infect Microbiol 11:766590. https://doi.org/10.3389/fcimb.2021.766590CrossRef

39.

Liu T, Zong H, Chen X, Li S, Liu Z, Cui X, Jia G, Shi Y (2022) Toll-like receptor 4-mediated necroptosis in the development of necrotizing enterocolitis. Pediatr Res 91(1):73–82. https://doi.org/10.1038/s41390-021-01457-yCrossRef

40.

Huang Z, Zhou T, Sun X, Zheng Y, Cheng B, Li M, Liu X, He C (2018) Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation. Cell Death Differ 25(1):180–189. https://doi.org/10.1038/cdd.2017.141CrossRef

41.

Wan R, Jiang J, Hu C, Chen X, Chen C, Zhao B, Hu X, Zheng Z, Li Y (2020) Neutrophil extracellular traps amplify neutrophil recruitment and inflammation in neutrophilic asthma by stimulating the airway epithelial cells to activate the TLR4/ NF-κB pathway and secrete chemokines. Aging (Albany NY) 12(17):16820–16836. https://doi.org/10.18632/aging.103479CrossRef

42.

Nirujogi TS, Kotha SR, Chung S, Reader BF, Yenigalla A, Zhang L, Shapiro JP, Wisler J, Christman JW, Maddipati K, Parinandi NL, Karpurapu M (2022) Lipidomic profiling of bronchoalveolar lavage fluid extracellular vesicles indicates their involvement in lipopolysaccharide-induced acute lung injury. J Innate Immun. https://doi.org/10.1159/000522338CrossRef

43.

Xu J-F, Gao Y-H, Song Y-L, Qu J-M, and Guan W-J (2022) Research advances and clinical management of bronchiectasis: Chinese perspective. ERJ Open Res, 8(2).https://doi.org/10.1183/23120541.00017-2022

44.

D’Orlando O, Zhao F, Kasper B, Orinska Z, Müller J, Hermans-Borgmeyer I, Griffiths GM, ZurStadt U, Bulfone-Paus S (2013) Syntaxin 11 is required for NK and CD8⁺ T-cell cytotoxicity and neutrophil degranulation. Eur J Immunol 43(1):194–208. https://doi.org/10.1002/eji.201142343CrossRef

45.

Misheva M, Kotzamanis K, Davies LC, Tyrrell VJ, Rodrigues PRS, Benavides GA, Hinz C, Murphy RC, Kennedy P, Taylor PR, Rosas M, Jones SA, McLaren JE, Deshpande S, Andrews R, Schebb NH, Czubala MA, Gurney M, Aldrovandi M, Meckelmann SW, Ghazal P, Darley-Usmar V, White DA, O’Donnell VB (2022) Oxylipin metabolism is controlled by mitochondrial β-oxidation during bacterial inflammation. Nat Commun 13(1):139. https://doi.org/10.1038/s41467-021-27766-8CrossRef

46.

Sokolov EN (1988) Trends and perspectives in the development of the physiology of higher nervous activity. Neurosci Behav Physiol 18(2):87–93CrossRef

47.

Evans S, Weinheimer CJ, Kovacs A, Williams JW, Randolph GJ, Jiang W, Barger PM, Mann DL (2020) Ischemia reperfusion injury provokes adverse left ventricular remodeling in dysferlin-deficient hearts through a pathway that involves TIRAP dependent signaling. Sci Rep 10(1):14129. https://doi.org/10.1038/s41598-020-71079-7CrossRef

48.

Ali J (2021) A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective. Expert Rev Respir Med 15(5):663–673. https://doi.org/10.1080/17476348.2021.1887734CrossRef

49.

Kim SJ, Yoon SH, Choi SM, Lee J, Lee C-H, Han SK, Yim J-J (2017) Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease : a prospective cohort study. BMC Pulm Med 17(1):5. https://doi.org/10.1186/s12890-016-0349-3CrossRef

Title: Necroptosis-related subtypes are associated with bronchiectasis in pulmonary non-tuberculous mycobacteria-infected patients: a perspective based on transcriptomic analysis
Authors: Hao Qian
Ai Ge
Ji-Jin Jiang
Jin-Fu Xu
Publication date: 05-12-2022
Publisher: Springer Berlin Heidelberg
Keywords: Bronchiectasis
Non-Tuberculous Mycobacteria
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2023
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-022-04532-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2023

Epidemiology of extrapulmonary tuberculosis in central Guangxi from 2016 to 2021

Vaccine certificates for international travelers in future pandemics

A multicentre evaluation and expert recommendations of use of the newly developed BioFire Joint Infection polymerase chain reaction panel

Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility

Evolving insights into the epidemiology of Moraxella species bloodstream infection from two decades of surveillance in Queensland, Australia

Diagnostic test accuracy of an automated device for the MALDI target preparation for microbial identification

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials